MediciNova, Inc. (MNOV) At $12.23 Forms Top; Shorts at Tyme Technologies (TYME) Raised By 39.22%

MediciNova, Inc. (MNOV) formed multiple top with $13.21 target or 8.00% above today’s $12.23 share price. MediciNova, Inc. (MNOV) has $500.60M valuation. The stock decreased 2.70% or $0.34 during the last trading session, reaching $12.23. About 12,897 shares traded. MediciNova, Inc. (NASDAQ:MNOV) has risen 98.80% since April 16, 2017 and is uptrending. It has outperformed by 87.25% the S&P500.

Tyme Technologies Inc (NASDAQ:TYME) had an increase of 39.22% in short interest. TYME’s SI was 924,700 shares in April as released by FINRA. Its up 39.22% from 664,200 shares previously. With 229,000 avg volume, 4 days are for Tyme Technologies Inc (NASDAQ:TYME)’s short sellers to cover TYME’s short positions. The SI to Tyme Technologies Inc’s float is 3.68%. The stock increased 1.81% or $0.0395 during the last trading session, reaching $2.2195. About 20,452 shares traded. Tyme Technologies, Inc. (NASDAQ:TYME) has declined 2.55% since April 16, 2017 and is downtrending. It has underperformed by 14.10% the S&P500.

Tyme Technologies, Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of cancer therapeutics for various oncology indications. The company has market cap of $221.51 million. It is developing SM-88, a combination therapy in Phase II development for prostate cancer. It currently has negative earnings.

Among 2 analysts covering Medicinova (NASDAQ:MNOV), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Medicinova has $2200 highest and $22 lowest target. $22’s average target is 79.89% above currents $12.23 stock price. Medicinova had 2 analyst reports since March 28, 2018 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, March 28 by FBR Capital.

Investors sentiment decreased to 1.79 in 2017 Q4. Its down 0.88, from 2.67 in 2017Q3. It dived, as 7 investors sold MediciNova, Inc. shares while 7 reduced holdings. 6 funds opened positions while 19 raised stakes. 7.63 million shares or 3.16% less from 7.88 million shares in 2017Q3 were reported. Parallax Volatility Advisers L P holds 4,998 shares or 0% of its portfolio. Bnp Paribas Arbitrage has invested 0% in MediciNova, Inc. (NASDAQ:MNOV). Voya Investment Mngmt Ltd Com holds 0% or 19,341 shares in its portfolio. Citigroup accumulated 9,573 shares or 0% of the stock. Fmr Limited Liability has 1.18 million shares for 0% of their portfolio. Jpmorgan Chase & reported 18,056 shares. Highland L P holds 0% in MediciNova, Inc. (NASDAQ:MNOV) or 16,272 shares. Tower Research Lc (Trc) reported 2,090 shares or 0% of all its holdings. Blackrock Inc invested 0% in MediciNova, Inc. (NASDAQ:MNOV). State Board Of Administration Of Florida Retirement holds 0% or 10,011 shares. Citadel Advsrs Limited Liability Corp owns 12,605 shares. State Bank Of New York Mellon holds 0% or 106,764 shares in its portfolio. California Pub Employees Retirement reported 42,600 shares. State Of Wisconsin Inv Board has 26,000 shares. Wells Fargo And Com Mn holds 0% in MediciNova, Inc. (NASDAQ:MNOV) or 45,350 shares.

MediciNova, Inc. (NASDAQ:MNOV) Institutional Positions Chart